 MedAvail Holdings, Inc.
|
42.88 |
|
ADC Therapeutics SA
|
18.57 |
 Fate Therapeutics
|
13.27 |
 Shattuck Labs, Inc.
|
11.84 |
 Zymeworks Inc.
|
9.19 |
 IGM Biosciences, Inc.
|
8.93 |
 Epizyme, Inc.
|
8.33 |
 Scholar Rock Holding Corporation
|
8.22 |
 Immunome
|
8.15 |
|
Lava Therapeutics B.V.
|
7.89 |
 REGENXBIO
|
7.67 |
 Atara Biotherapeutics
|
7.63 |
|
Absci Corporation
|
7.3 |
 ALX Oncology Holdings Inc.
|
7.3 |
 Annexon, Inc.
|
7.02 |
 ImmunoGen
|
6.57 |
 Replimune Group, Inc.
|
6.3 |
 Neoleukin Therapeutics, Inc.
|
6.2 |
 Krystal Biotech, Inc.
|
6.08 |
 Gritstone Oncology, Inc.
|
5.99 |
 Deciphera Pharmaceuticals, Inc.
|
5.94 |
 Stoke Therapeutics, Inc.
|
5.67 |
 Amicus Therapeutics, Inc.
|
5.02 |
 Repare Therapeutics Inc.
|
4.75 |
 Pliant Therapeutics, Inc.
|
4.48 |
 Allakos Inc.
|
4.18 |
|
Achilles Therapeutics plc
|
3.91 |
|
Entrada Therapeutics, Inc.
|
3.82 |
|
RayzeBio, Inc. Common Stock
|
3.1 |
 IVERIC bio, Inc.
|
3.05 |
 Stereotaxis, Inc.
|
1.84 |
 TCR2 Therapeutics Inc.
|
1.68 |
 AlloVir, Inc.
|
1.66 |
 Zymergen Inc.
|
1.49 |
|
Atreca, Inc.
|
1.35 |
|
Invivyd, Inc.
|
1.31 |
 Eidos Therapeutics, Inc.
|
1.21 |
 HOOKIPA Pharma Inc.
|
1.1 |
|
Prime Medicine, Inc.
|
1.1 |
|
Science 37 Holdings, Inc.
|
0.83 |
 Invitae Corporation
|
0.8 |
|
Alpha Teknova, Inc.
|
0.39 |
|
Augmedix, Inc.
|
0 |
